During the past decade, Mediciti Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mediciti Hospital" #1 sponsor was "United Therapeutics" with 2 trials, followed by "Adocia" with 1 trials sponsored, "CymaBay Therapeutics, Inc." with 1 trials sponsored, "Stem Cell Therapeutics Corp." with 1 trials sponsored and "Stempeutics Research Pvt Ltd" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mediciti Hospital" #1 collaborator was "Medical Health Research Infrastructure Council, Australia" with 1 trials as a collaborator, "National Health and Medical Research Council, Australia" with 1 trials as a collaborator, "National Heart Foundation, Australia" with 1 trials as a collaborator and "Virchow Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Mediciti Hospital" are "Pulmonary Arterial Hypertension" (2 trials), "Stroke" (2 trials), "Alcoholic Liver Cirrhosis" (1 trials), "Diabetic Foot Ulcer" (1 trials) and "Transient Ischemic Attack" (1 trials). Many other conditions were trialed in "Mediciti Hospital" in a lesser frequency.

Most popular intervention types in "Mediciti Hospital" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo" (1 trials), "Actos" (1 trials), "Allogeneic Mesenchymal Stem Cells" (1 trials) and "BioChaperone PDGF-BB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mediciti Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Mediciti Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mediciti Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mediciti Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".